GI
RPRX icon

GAMMA Investing’s Royalty Pharma RPRX Stock Holding History

GAMMA Investing’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$326K Sell
5,585
-10
-0.2% -$590 0.01% 974
2026
Q2 		$314K Buy
5,595
+789
+16% +$41.1K 0.01% 943
2026
Q1 		$231K Buy
4,806
+618
+15% +$27.1K 0.01% 1013
2025
Q4 		$162K Buy
4,188
+882
+27% +$33.6K 0.01% 1190
2025
Q3 		$117K Buy
3,306
+289
+10% +$10.5K 0.01% 1386
2025
Q2 		$109K Buy
3,017
+440
+17% +$14.6K 0.01% 1380
2025
Q1 		$80.2K Buy
2,577
+106
+4% +$3.36K 0.01% 1440
2024
Q4 		$63K Buy
2,471
+590
+31% +$15.6K 0.01% 1476
2024
Q3 		$53.2K Buy
1,881
+256
+16% +$7.09K 0.01% 1452
2024
Q2 		$42.9K Sell
1,625
-13
-0.8% -$360 0.01% 1309
2024
Q1 		$49.7K Buy
1,638
+1,037
+173% +$30.6K 0.01% 1052
2023
Q4 		$17.1K Buy
+601
New +$16.5K ﹤0.01% 1607

Other funds holding RPRX

EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
KA
Kearns & Associates Palos Verdes Estates, California $218M AUM 16.36% 1-Year Est. Return
MGI
Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 31.62% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

GAMMA Investing's RPRX Position: Q3 2026 in Review

GAMMA Investing reduced its Royalty Pharma (RPRX) stake by 0.18% in Q3 2026, selling an estimated $590 and leaving 5,585 shares worth $326K. The position accounts for 0.01% of the portfolio, ranked #974.

GAMMA Investing first reported a position in RPRX in Q4 2023 and has held it in 12 quarters since. 21 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • GAMMA Investing held 5,585 shares of Royalty Pharma worth $326K as of Q3 2026.
  • GAMMA Investing sold 10 Royalty Pharma shares in Q3 2026, an estimated $590.
  • Royalty Pharma made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #974 holding.
  • GAMMA Investing first reported a position in Royalty Pharma in Q4 2023 and has held it in 12 quarters since.
  • 21 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.